Several factors are associated with overall and progression-free survival in patients with limited-stage small cell lung cancer receiving chemoradiotherapy, according to researchers.
Researchers sought to better understand the experiences of patients living with multiple myeloma and their perceptions of palliative care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback